Fixed drug eruption due to rifampin

Leprosy Review

Volumn 69, Issue 4, 1998, Pages 397-399

  John, Stephen S ^a  

^a St Joseph's Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; DRUG ERUPTION; FEMALE; HUMAN; HYPERPIGMENTATION; LEPROSY; TUBERCULOSIS; URTICARIA;

EID: 0032408723     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19980041     Document Type: Article

References (24)

1. Girling DJ, Hitze HL. Adverse reactions to rifampicin. Bull World Health Org, 1979; 57: 45-49.
2. Naik RPC, Balachandran C, Ramnarayan K. Fixed eruption due to rifampicin. Ind J Lepr, 1985; 57: 648-650.
3. Bourns DCG. Unusual effects of antipyrine. Br Med J, 1889; 2: 818-820.
4. Breathnach SM. Drug reactions. In: Textbook of dermatology, 5th edn, Champion RH, Burton JL, Ebling FJG (eds) Blackwell, Oxford, 1992; Chapter 74.
5. Pasricha JS. Drugs causing fixed eruptions. Br J Dermatol, 1979; 100: 183-185.
6. Savin JA. Current causes of fixed drug eruptions. Br J Dermatol, 1970; 83: 546-549.
7. Welsh AL. The fixed eruption. A possible hazard of modern drug therapy. Charles C Thomas, Springfield IL, 1961: 208. (quoted in: Sehgal VN, Gangwani OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67-74.
8. Welsh AL. The fixed eruption. A possible hazard of modern drug therapy. Charles C Thomas, Springfield IL, 1961: 208. (quoted in: Sehgal VN, Gangwani OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67-74.
9. Wyatt E, Greaves M, Sondergaard J. Fixed drug eruption (phenolphthalein): evidence for a blood-borne mediator. Arch Dermatol, 1972; 106: 671-673.
10. Gimenez-Camarasa JM, Garcia-Calderon P, deMoragas JM. Lymphocyte transformation test in fixed drug eruption. N Engl J Med, 1975; 292: 819-821.
11. Theodoridis A, Tsabaos T. Sivensac eruption: serum immunoglobulins in fixed drug eruptions. Acta Dermatovener, 1977; 57: 507-508. (quoted in: Sehgal VN, Gangwani OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67-74.)
12. Theodoridis A, Tsabaos T. Sivensac eruption: serum immunoglobulins in fixed drug eruptions. Acta Dermatovener, 1977; 57: 507-508. (quoted in: Sehgal VN, Gangwani OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67-74.)
13. David IP, Stanley G. Fixed drug eruption: in autoradiographic study of exchange graft. Br J Dermatol, 1969; 81: 171-174.
14. Korkij W, Soltani K. Fixed drug eruption: a brief review. Arch Dermatol, 1984; 120: 520-524.
15. Gange RN, Rhodes EL, Edwards CO, Powell MEA. Pemphigus induced by rifampicin. Br J Dermatol, 1976; 95: 445.
16. Lee CW, Lim JH, Kang HJ. Pemphigus foliaceus induced by rifampicin. Br J Dermatol, 1984; 111: 619-622.
17. Harry M Goldwin, William J Scheweitzer, Darryl N Bronson. Rifampicin and exfoliative dermatitis. Ann Int Med, 1987; 107: 789.
18. Uchenna Nwokolo. Acneiform lesions in combined rifampicin treatment in Africans. Br Med J, 1974; 3: 473.
19. Gupta CM, Bhate RD. Shortness of breath with urticaria due to once monthly rifampicin. Lepr Rev, 1987; 58: 308.
20. Nyirenda R, Gill GV. Stevens-Johnson syndrome due to rifampicin. Br Med J, 1977, 4: 1189.
21. Girling DJ. Adverse effects of antituberculous drugs. Drugs, 1982; 23: 56-74.
22. Milpied B et al. Contact dermatitis from rifamycin. Contact Dermatitis, 1986; 14: 252-253.
23. Wurtz RM, Abrams D, Becker S, Jocobson MA, Mass MM, Marks SH. Anaphylaxis from rifampicin (letter). Am J Med, 1992; 92: 581-582.
24. Harland RW et al. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients (letter). Lancet, 1989; 1: 955-956.